Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Nordisk is still only about one-tenth the size of Novo overall, but they're a third the size of Novo's insulin business. And they've moved from being this licensing company to now an actual production company with capacity all around the world. So this is a huge win from, like, basically they were going to be taken over for cash by their old rivals, and now they're back in the game.
0
💬
0
Comments
Log in to comment.
There are no comments yet.